DexCom Profile

99.72
USD 1.09  1.08%
91%
81%

Conversion by Olson Nancy S of 210869 shares of DexCom

DexCom insider trading alert for conversion of common stock by Olson Nancy S, the corporate stakeholder, on June 19, 2018. This event was filed by Dexcom Inc with SEC on 2005-04-21. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

DexCom Summary

DexCom (DXCM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 2,290 people. DexCom is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 8.78 B. DexCom conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 88.08 M outstanding shares of which 12.17 M shares are currently shorted by private and institutional investors with about 7.5 trading days to cover. DEXCOM currently holds about 548.6 M in cash with 92 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.31.
Check DexCom Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 99.72HorizonTargetOdds Above 99.72
91.45%30 days 99.72 8.46%
Based on normal probability distribution, the odds of DexCom to move above current price in 30 days from now is about 8.46% (This DexCom probability density function shows the probability of DexCom Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Price T Rowe Associates IncCommon Shares8.9 M662.4 M
Fmr LlcCommon Shares7.3 M544 M
View DexCom Diagnostics

Selected DexCom Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

DexCom Against Markets

Risk Adjusted
Performance Score (0 to 100)
23 
Chance of
Financial Distress (0 to 100%)
2 
Equity ratings for DexCom are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DexCom operates under Diagnostics Research classification in USA and traded on NASDAQ. It employs 2290 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameDexCom
CEO and President and DirectorKevin SayerView All
Thematic Classification
Currently Active Investing Idea
  Medical Equipment
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Equipment
InstrumentUSA Stock View All
RegionNorth America
LocationCALIFORNIA, U.S.A
Business Address6340 Sequence Drive
ExchangeNASDAQ
CIK Number01093557.0
ISINUS2521311074
CUSIP252131107
SectorHealthcare
IndustryMedical Equipment
BenchmarkDOW
Websitewww.dexcom.com
Contact Number858 200 0200
CurrencyUSD - US Dollar

Recommendations

DexCom Analyst Recommendations
Target PriceAdvice# of Analysts
85.31Buy16Odds
DexCom current and past analyst recommendations published by number of research institutions as well as average analyst consensus
DexCom Analyst Advice  

Earnings

DexCom Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.18April 26, 2017
DexCom normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

DexCom Corporate Directors
Eric Topol Independent Director, Ph.D
Nicholas Augustinos Independent Director
Mark Foletta Independent Director, CPA
Additionally see Investing Opportunities. Please also try CEO Directory module to screen ceos from public companies around the world.